Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,846.73
4,250.66
4,237.86
3,971.23
3,621.63
3,303.27
3,204.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,846.73
4,250.66
4,237.86
3,971.23
3,621.63
3,303.27
3,204.46
Raw Material Cost
3,215.07
3,413.41
3,229.61
2,925.16
2,626.04
2,194.43
2,026.78
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
35.68
31.25
34.64
35.74
42.00
43.87
42.05
Selling and Distribution Expenses
432.72
601.58
728.10
801.71
759.96
893.45
986.74
Other Expenses
1.15
2.97
4.04
2.77
3.20
2.92
3.40
Total Expenditure (Excl Depreciation)
3,695.01
4,075.97
4,032.72
3,790.36
3,459.95
3,160.96
3,089.55
Operating Profit (PBDIT) excl Other Income
151.7
174.7
205.10000000000002
180.9
161.70000000000002
142.3
114.9
Other Income
40.61
64.58
57.02
57.16
45.24
64.64
49.30
Operating Profit (PBDIT)
324.58
387.56
395.59
360.13
327.26
274.18
240.75
Interest
35.68
31.25
34.64
35.74
42.00
43.87
42.05
Exceptional Items
-2.65
-5.28
-6.92
11.08
0.83
-3.51
2.34
Gross Profit (PBDT)
631.67
837.25
1,008.25
1,046.07
995.60
1,108.85
1,177.68
Depreciation
161.07
142.30
139.15
133.18
126.25
87.05
81.09
Profit Before Tax
125.18
208.73
214.88
202.29
159.83
139.74
119.94
Tax
30.38
51.07
57.60
51.35
41.98
36.02
39.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
99.42
160.83
159.29
154.43
122.98
103.72
80.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
99.42
160.83
159.29
154.43
122.98
103.72
80.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.61
-3.18
-1.99
-3.49
-5.13
-1.62
-0.31
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
94.80
157.65
157.30
150.94
117.86
102.10
80.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,104.08
2,019.57
1,889.41
1,728.49
1,741.79
1,413.49
1,324.32
Earnings per share (EPS)
0.21
0.35
0.34
0.35
0.28
0.24
0.19
Diluted Earnings per share
0.21
0.35
0.34
0.35
0.28
0.24
0.19
Operating Profit Margin (Excl OI)
3.19%
4.25%
4.71%
4.28%
4.3%
3.71%
3.44%
Gross Profit Margin
7.44%
8.26%
8.35%
8.45%
7.9%
6.87%
6.27%
PAT Margin
2.58%
3.78%
3.76%
3.89%
3.4%
3.14%
2.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -9.50% vs 0.30% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -39.89% vs 0.25% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -12.07% vs -4.61% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 14.06% vs -9.54% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Anhui Fengyuan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
3,846.73
0
3,846.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,846.73
0
3,846.73
Raw Material Cost
3,215.07
0
3,215.07
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
35.68
0
35.68
Selling and Distribution Expenses
432.72
0
432.72
Other Expenses
1.15
0.00
1.15
Total Expenditure (Excl Depreciation)
3,695.01
0
3,695.01
Operating Profit (PBDIT) excl Other Income
151.73
0.00
151.73
Other Income
40.61
0
40.61
Operating Profit (PBDIT)
324.58
0
324.58
Interest
35.68
0
35.68
Exceptional Items
-2.65
0
-2.65
Gross Profit (PBDT)
631.67
0
631.67
Depreciation
161.07
0
161.07
Profit Before Tax
125.18
0
125.18
Tax
30.38
0
30.38
Provisions and contingencies
0
0
0.00
Profit After Tax
99.42
0
99.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
99.42
0
99.42
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.61
0
-4.61
Other related items
0.00
0.00
0.00
Consolidated Net Profit
94.80
0
94.80
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,104.08
0
2,104.08
Earnings per share (EPS)
0.21
0
0.21
Diluted Earnings per share
0.21
0
0.21
Operating Profit Margin (Excl OI)
3.19%
0%
0.00
3.19%
Gross Profit Margin
7.44%
0%
0.00
7.44%
PAT Margin
2.58%
0%
0.00
2.58%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 384.67 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -9.50% vs 0.30% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 9.48 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -39.89% vs 0.25% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.40 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -12.07% vs -4.61% in Dec 2024
Annual - Interest
Interest 3.57 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 14.06% vs -9.54% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.19%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






